Oxolamine citrate
- Level
- Commodity
- Parent
- 51381900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51381907This classification denotes an antitussive agent with the molecular formula C14H19N3O.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K5X4XBR694, chemically known as 1,2,4-oxadiazole, 5-(2-(diethylamino)ethyl)-3-phenyl-, citrate but more generally known as oxolamine citrate, which bears US NIH Compound Identifier 16045. European Medicines Agency schedules Oxolamine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03576MIG. Most nations, for tariff and trade purposes, schedule oxolamine citrate under HS 29349990 and SITC 51579. As of Q4 2014, OXOLAMINE CITRATE remains US FDA's Preferred Term for this commodity. SMILES: CCN(CC)CCC1NC(NO1)C2CCCCC2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.
Same parent
Under 51381900 · 10Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.